Shandong Weifang Rainbow Chemical Valuation
Is 301035 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 301035 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 301035 (CN¥64.86) wird über unserer Schätzung des Fair Value (CN¥26.71) gehandelt.
Deutlich unter dem Marktwert: 301035 über unserer Schätzung des beizulegenden Zeitwerts gehandelt wird.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 301035?
Other financial metrics that can be useful for relative valuation.
| What is 301035's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CN¥16.35b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.3x |
| Enterprise Value/EBITDA | 13.4x |
| PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does 301035's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 20.8x | ||
002312 Sichuan Development LomonLtd | 48.8x | 51.3% | CN¥13.5b |
000902 YONFER Agricultural Technology | 12.7x | 22.6% | CN¥14.0b |
600486 Jiangsu Yangnong Chemical | 14.3x | 13.8% | CN¥22.4b |
603599 Anhui Guangxin Agrochemical | 7.4x | 16.9% | CN¥13.2b |
301035 Shandong Weifang Rainbow Chemical | 21.2x | 37.1% | CN¥16.3b |
Price-To-Earnings gegen Gleichaltrige: 301035 ist auf der Grundlage des Price-To-Earnings Verhältnisses (21.2x) im Vergleich zum Durchschnitt der Vergleichsgruppe (20.8x) teuer.
Price to Earnings Ratio vs Industry
How does 301035's PE Ratio compare vs other companies in the CN Chemicals Industry?
Price-To-Earnings gegen Industrie: 301035 ist aufgrund seines Price-To-Earnings Verhältnisses (21.8x) im Vergleich zum CN Chemicals Branchendurchschnitt (26.9x) ein guter Wert.
Price to Earnings Ratio vs Fair Ratio
What is 301035's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 21.2x |
| Fair PE Ratio | 27.6x |
PM vs. Fair Ratio: 301035 ist ein guter Wert auf der Grundlage des Verhältnisses Price-To-Earnings (22.3x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Earnings (22.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CN¥58.66 | CN¥88.67 +51.2% | 1.5% | CN¥90.00 | CN¥87.34 | n/a | 2 |
| Mar ’25 | CN¥67.07 | CN¥88.67 +32.2% | 1.5% | CN¥90.00 | CN¥87.34 | n/a | 2 |
| Feb ’25 | CN¥54.80 | CN¥88.67 +61.8% | 1.5% | CN¥90.00 | CN¥87.34 | n/a | 2 |
| Jan ’25 | CN¥70.00 | CN¥88.67 +26.7% | 1.5% | CN¥90.00 | CN¥87.34 | n/a | 2 |
| Dec ’24 | CN¥74.50 | CN¥88.67 +19.0% | 1.5% | CN¥90.00 | CN¥87.34 | n/a | 2 |
| Nov ’24 | CN¥68.80 | CN¥89.11 +29.5% | 1.4% | CN¥90.00 | CN¥87.34 | n/a | 3 |
| Oct ’24 | CN¥71.50 | CN¥97.56 +36.4% | 11.0% | CN¥112.68 | CN¥90.00 | n/a | 3 |
| Sep ’24 | CN¥76.00 | CN¥97.56 +28.4% | 11.0% | CN¥112.68 | CN¥90.00 | n/a | 3 |
| Aug ’24 | CN¥80.51 | CN¥97.56 +21.2% | 11.0% | CN¥112.68 | CN¥90.00 | n/a | 3 |
| Jul ’24 | CN¥78.57 | CN¥97.56 +24.2% | 11.0% | CN¥112.68 | CN¥90.00 | n/a | 3 |
| Jun ’24 | CN¥80.98 | CN¥97.56 +20.5% | 11.0% | CN¥112.68 | CN¥90.00 | n/a | 3 |
| May ’24 | CN¥74.10 | CN¥100.89 +36.2% | 15.3% | CN¥122.68 | CN¥90.00 | n/a | 3 |
| Apr ’24 | CN¥68.49 | CN¥105.24 +53.7% | 14.5% | CN¥120.48 | CN¥90.00 | CN¥67.58 | 2 |
| Mar ’24 | CN¥77.92 | CN¥120.24 +54.3% | 0.2% | CN¥120.48 | CN¥120.00 | CN¥67.07 | 2 |
| Feb ’24 | CN¥78.66 | CN¥120.24 +52.9% | 0.2% | CN¥120.48 | CN¥120.00 | CN¥54.80 | 2 |
| Jan ’24 | CN¥87.10 | CN¥113.84 +30.7% | 5.4% | CN¥120.00 | CN¥107.67 | CN¥70.00 | 2 |
| Dec ’23 | CN¥91.46 | CN¥113.84 +24.5% | 5.4% | CN¥120.00 | CN¥107.67 | CN¥74.50 | 2 |
| Nov ’23 | CN¥90.88 | CN¥113.84 +25.3% | 5.4% | CN¥120.00 | CN¥107.67 | CN¥68.80 | 2 |
| Aug ’23 | CN¥75.45 | CN¥84.25 +11.7% | 0.9% | CN¥85.00 | CN¥83.50 | CN¥80.51 | 2 |
| Jul ’23 | CN¥80.29 | CN¥84.25 +4.9% | 0.9% | CN¥85.00 | CN¥83.50 | CN¥78.57 | 2 |
| Jun ’23 | CN¥72.98 | CN¥84.25 +15.4% | 0.9% | CN¥85.00 | CN¥83.50 | CN¥80.98 | 2 |
Analysten-Prognose: Das Kursziel liegt mehr als 20% über dem aktuellen Aktienkurs, aber es gibt nicht genügend Analysten, die die Aktie beobachten, um eine statistische Sicherheit für eine Übereinstimmung zu ermitteln.